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Multiple surgical targets for treating obsessive-compulsive disorder with deep brain stimu-
lation (DBS) have been proposed. However, different targets may modulate the same neural
network responsible for clinical improvement. We analyzed data from four cohorts of patients
(N= 50) that underwent DBS to the anterior limb of the internal capsule (ALIC), the nucleus
accumbens or the subthalamic nucleus (STN). The same fiber bundle was associated with
optimal clinical response in cohorts targeting either structure. This bundle connected frontal
regions to the STN. When informing the tract target based on the first cohort, clinical
improvements in the second could be significantly predicted, and vice versa. To further
confirm results, clinical improvements in eight patients from a third center and six patients
from a fourth center were significantly predicted based on their stimulation overlap with this
tract. Our results show that connectivity-derived models may inform clinical improvements
across DBS targets, surgeons and centers. The identified tract target is openly available
in atlas form.
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Obsessive-compulsive disorder (OCD) is a debilitatingdisease with a life-time prevalence of around 2.3%1.Treatment of severe cases by deep brain stimulation
(DBS) to the ALIC has been approved by the FDA (Humanitarian
Device Exemption) in 20092. A variety of other targets have been
proposed, however, including the STN3,4, nucleus accumbens
(NAcc)5, ventral capsule/ventral striatum (VC/VS)6, inferior
thalamic peduncle (ITP)7, bed nucleus of the stria terminalis
(BNST)8, anteromedial globus pallidus interna (amGPi)9, super-
olateral branch of the medial forebrain bundle (slMFB)10 and
medial dorsal and ventral anterior nuclei of the thalamus (MD/
vANT)11 (for an overview see ref. 12). A recent prospective
clinical trial implanted four electrodes per patient with one pair in
the STN and one in the ALIC13.
In parallel, DBS has experienced a conceptual paradigm-shift
away from focal stimulation of specific brain nuclei (such as the
subthalamic nucleus or globus pallidus in Parkinson’s disease;
PD) toward modulating distributed brain networks (such as the
motor basal-ganglia cortical cerebellar loop in PD)10,14–17.
Although the concept of modulating white-matter tracts (instead
of gray matter nuclei) is certainly not new (and anterior capsu-
lotomy was introduced in the ~1950s by Talairach and Leksell18),
novel MRI technologies such as diffusion-weighted imaging-
based tractography are now increasingly used in functional
neurosurgery in order to more deliberately target white-matter
tracts16. In this translational development, the Coenen and
Mayberg groups should be explicitly mentioned, among others,
for pioneering and rapidly translating the use of tractography to
functional surgery since around 200910,14,15,19.
It could be possible that, of the multiple targets proposed, some
—or most—may in fact modulate the same brain network to
alleviate symptoms. Such a concept has been proposed in the past
by Schlaepfer and colleagues for the case of treatment-refractory
depression20. Namely, the superolateral branch of the medial
forebrain bundle may connect most if not all surgical targets that
were proposed for treatment of depression (e.g. subgenual cortex,
ALIC, NAcc, habenula). Thus, in theory, the tract itself could be a
surgical target—and could be modulated in a similar way when
targeting various points along its anatomical course. Accordingly,
already, Coenen et al.10 surgically implanted electrodes to directly
target this tract instead of a localized target, also in OCD. The
tract connected the ventral tegmental area and the prefrontal
cortex and authors referred to it as the superolateral branch of the
medial forebrain bundle.
Other invasive therapies, such as cingulotomy and capsu-
lotomy also aimed at disrupting connectivity from frontal regions
by lesioning white-matter bundles21. It could recently be shown
that such tract- or network-based concepts may be used to predict
clinical improvements across DBS centers and surgeons for the
case of Parkinson’s disease22,23. Based on modern neuroimaging
methods and high-resolution connectomic datasets, connectivity
of DBS electrodes to specific cortical regions was associated with
stronger therapeutic effects in various diseases treated with this
surgical procedure22,24–26.
For the case of OCD, Baldermann et al.24 recently demon-
strated that structural connectivity from DBS electrodes to medial
and lateral prefrontal cortices was associated with stronger
symptom alleviation. Crucially, they were also able to identify a
specific subsection of the ALIC that was highly associated with
symptom improvements after one year of DBS. Of note, con-
nectivity to this fiber tract was able to predict ~40% of the var-
iance in clinical outcome in out-of-sample data. The bundle
connected to both medial dorsal nucleus of the thalamus and to
the anterior part of the STN (which have received substantial
attention in the context of OCD). The STN itself is a prominent
target for DBS of various diseases including PD, dystonia, OCD
and Tourette’s syndrome27. The small nucleus receives wide-
spread direct afferents from most parts of the prefrontal cortex
and is involved in motor, associative and limbic processing28. Due
to these spatially organized cortico-subthalamic projections, the
nucleus has functional zones that largely follow the organization
of the frontal cortex, i.e. sensorimotor parts of the STN are
situated posterior, followed by pre-/oculomotor-, associative and
limbic domains in anteromedial direction.
Consequently, the anterior (associative/limbic) parts of the
STN have been targeted by DBS for OCD29; these same anterior
subregions were exclusively connected to the tract target identi-
fied by Baldermann et al.24 in ALIC-DBS patients. Following up
on this, our present study aimed at testing whether the same tract
could be associated with good clinical outcome in a cohort treated
with STN-DBS. We retrospectively analyzed two cohorts of DBS
patients that were treated with either STN-DBS or ALIC-DBS in
order to test our hypothesis, that the same tract could potentially
predict clinical improvement in STN-DBS as well as ALIC-DBS.
In this attempt, we identified a common tract that already became
apparent when analyzing either cohort alone. After calculating
the tract exclusively based on data of one cohort (e.g. ALIC), we
cross-predicted outcome in the other cohort (e.g. STN), and vice
versa. We then tested predictive utility of this tract in two addi-
tional cohorts from a third and fourth center. Finally, we set the
resulting tract target into the larger context of OCD-DBS litera-
ture and tested, whether it could be used to explain outcomes of
reported clinical studies with different surgical targets.
Results
Clinical results. Two cohorts (Cologne; ALIC target; N= 22; and
Grenoble; STN target; N= 14, two electrodes in each patient)
formed a training and cross-validation sample in which the tract
target was identified and validated. Each of the two cohorts were
first analyzed independently, then used to cross-predict outcome
in patients from the other one. The main part of our analyses
focuses on these two cohorts. As further validation of results, two
additional test cohorts were included (Madrid: two electrodes in
each patient targeting bilateral nucleus accumbens (NAcc);
London: four electrodes in each patient targeting bilateral ALIC
and STN).
Patients in all cohorts were of similar age with a similar
Y-BOCS score at baseline and comparable Y-BOCS improvement
scores (Table 1). In the first test cohort (Madrid; NAcc target;
N= 8), improvement scores were taken after activating each of
the four electrode contact pairs for 3 months, respectively
(following the clinical protocol described in ref. 30). This resulted
in a total of 32 data points. In the second test cohort (London;
both ALIC and STN target; N= 6, four electrodes in each
patient), stimulation parameters resulted from an optimized
phase following parameter optimization.
Electrode localization confirmed accurate placement to each of
the three target regions for all patients of the four cohorts (Fig. 1).
Connectivity analysis. Connectivity analysis results seeding from
electrodes of the two training cohorts (Cologne and Grenoble)
based on the N= 985 HCP normative connectome are shown in
Fig. 2. The overall connectivity of electrodes to other areas in the
brain (without weighing for clinical improvement) was strikingly
different between the two cohorts (Fig. 2, top row). This is hardly
surprising as it mainly reflects the overall structural connectivity
profiles of the two DBS targets. The STN as a widely connected
basal-ganglia entry point and the ALIC as a white-matter struc-
ture are differently connected in the brain. However, when tracts
were weighted by their ability to discriminate between good and
poor responders (using the fiber T-score method described
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below), a positively discriminative tract to the medial prefrontal
cortex emerged in each cohort even when cohorts were analyzed
independently (Fig. 2, middle row). The degree of lead con-
nectivity to this tract correlated with clinical improvement (R=
0.63 at p < 0.001 in the ALIC cohort and R= 0.77 at p < 0.001 in
the STN cohort; Fig. 2, bottom row).
Of note, these correlations are somewhat circular and meant to
describe the degree of how well discriminative tracts could
explain the same sample of patients on which they were
calculated. More interestingly, in the next step, the tract was
calculated exclusively on data from the STN cohort and then used
to explain outcome in the ALIC cohort (R= 0.50 at p= 0.009)
and vice versa (R= 0.49 at p= 0.041; Fig. 3).
Crucially, some VTAs of the ALIC cohort resided entirely
below the identified tract and thus received a fiber T-score of
(near) zero (also see blue example patient in Fig. 3, bottom right).
The same holds true when either calculating the tract based on
the STN cohort (Fig. 3) or the ALIC cohort itself (Fig. 2). To
further investigate this matter, two-sample t-tests between
improvements of patients with near-zero scores (fiber T-scores
below 50) and the remaining patients with VTAs covering the
tract well (scores above 50) were calculated. This showed that
















Reference(s) [22, 31] [28] [40] [16]
N of patients (females) 22 (12) 14 (9) 8 (4) 6 (1)
N of electrodes 44 28 16 24
Age 41.7 ± 20.5 41 ± 9 35.3 ± 10.4 45.5 ± 10.5
Y-BOCS baseline 31.3 ± 4.4 33.4 ± 3.7 30 ± 7.75 36.2 ± 1.8
Y-BOCS after DBS 20.7 ± 7.7 (12 months
postop)
19.6 ± 10.6 (12 months
postop)
14.75 ± 7.2 (3 months postop of
best contact)




9.6 ± 6.5 13.8 ± 10.8 15.1 ± 9.6 21.83 ± 5.7
% Y-BOCS Improvement 31.0 ± 20.5% 41.2 ± 31.7% 47.8 ± 23 50.0 ± 12.6%
Cologne ALIC (N = 22)
Grenoble STN (N = 14)
Caudate Putamen Accumbens Ventral pallidum STN GPi
London ALIC/STN (N = 6)
Madrid NAcc (N = 8)
Fig. 1 Overview of lead electrode placement. The two training/cross-validation cohorts (left) targeting ALIC (Cologne) and STN (Grenoble), and the two
test cohorts (right) targeting NAcc (Madrid) and both ALIC & STN with four electrodes per patient (London) are shown. Subcortical structures defined by
CIT-168 Reinforcement Learning Atlas63 (ALIC/NAcc region) and DISTAL Atlas64 (STN region), with coronal and axial planes of the T1-weighted ICMB
152 2009b nonlinear template as background.
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VTAs with large overlap with the tract resulted in significantly
better clinical improvement (T= 6.0 at p < 10−5 when the tract
was calculated on the ALIC cohort, Fig. 2, and T= 3.7 at
p < 0.005 when it was calculated on the STN cohort, Fig. 3).
Depending on the target, the analysis revealed different
proportions of “positive” and “negative” fibers (ALIC cohort:
22.2k positive vs. 1.9k negative fiber tracts selected from the group
connectome; STN cohort: 45.1k positive vs. 48.6k negative fibers
and both cohorts combined: 54.4k positive vs. 9.6k negative fibers).
Replication on independent test cohorts. In the next step, the
analysis was performed on the two cohorts combined. Again, the
same tract emerged, now even more clearly (Fig. 4, top). Bundles
were selected from the connectome and visualized, that were
predominantly connected with VTAs of patients from both
cohorts with good (red) or poor (blue) improvement, respectively.
The resulting positive discriminative tract traversed slightly dorsal
to the group of electrodes of the ALIC cohort and coursed cen-
trally or slightly ventral to the electrodes of the STN cohort. This
tract was then used to predict outcome in two independent test
cohorts of patients that underwent surgery in a third and fourth
center (Madrid & London; Fig. 4, bottom). Although the surgical
target of the Madrid cohort was the NAcc, electrode placement
was comparable to the ALIC/Cologne cohort (Fig. 1). Here,
improvements were taken for each contact pair that had been
switched on during a 3-month interval, leading to 32 data points
(Fig. 4, bottom left, active contact pair color coded). In the
London cohort, patients had received two electrodes to each
target (four in total) and fiber T-scores scores were summed up
across targets. In both test cohorts, stimulation overlap with the
tract target significantly correlated with empirical improvement
(Madrid: R= 0.50 at p < 0.001, London: R= 0.75 at p= 0.040).
Of note, VTAs in the London sample were estimated with a
different software (see Methods), patients received four electrodes
and the clinical scores represented an “optimized” phase follow-
ing 9 months of a clinical trial13.
Given the high amount of false-positive connections present in
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Fig. 2 Predictive fiber tracts in training cohorts. Top: all fibers connected to the sum of volumes of tissue activated (VTAs) of each cohort are shown in
green. Middle: predictive fibers positively associated with clinical improvement are shown in red. Only positive fibers are shown here for reasons of clarity.
See Fig. 3 for negatively associated tracts. The top 20% predictive fibers are displayed. Bottom: correlations between the degree of stimulating positively
predictive tracts (sum of aggregated fiber T-scores under each VTA) and clinical improvements. Gray shaded areas represent 95% confidence intervals.
This analysis is based on a normative connectome, a replication of it based on anatomically predefined pathways is shown in Supplementary Fig. 1.
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study using a synthesized anatomical atlas that is based on
established anatomical knowledge17 and thus free of such false-
positive connections. Results were highly similar and identified
the hyperdirect pathway connecting the dorsal anterior cingulate
cortex (dACC) to the STN to be most associated with clinical
outcome (Supplementary Figs. 1 and 2).
A tract target for OCD-DBS. The tract target identified here may
potentially “unify” some aspects of the STN and ALIC/NAcc
targets for OCD. Thus, in a final analysis, we aimed at setting it
into context with other DBS targets that were used in OCD-DBS,
before. To do so, we converted literature-based targets into
template space32 and set them into relation with the tract target
(see Fig. 5, Table 2 and Supplementary Methods). A large number
of reported DBS targets for OCD seemed to cluster on or around
the tract. Furthermore, clinical improvement values that had been
reported in these studies could be significantly accounted for by
calculating the weighted overlap between stereotactic target sites
and the tract (Fig. 5c, see Supplementary Methods for details).
Given the potential clinical importance of the identified tract,
we estimated a final version of the tract based on all four cohorts
and characterized its anatomical properties using additional views
relative to anatomical landmarks (Fig. 6 and Supplementary
Fig. 3). Anatomically, the tract is a subpart of the well-
characterized ALIC that connects areas of the prefrontal cortex
with the subthalamic nucleus and MD nucleus of the
thalamus33,34. Anatomical validity of the isolated tract was
discussed with four anatomists and further experts in the field
(see Acknowledgements section). In the motor domain, the
“hyperdirect pathway”, i.e., a direct connection from frontal
cortex to subthalamic nucleus, has been well established35,36,
functionally, but the STN is known to receive widespread and
direct input from widespread areas of the prefrontal cortex33.
Thus, the main part of the specific bundle delineated here may
represent a route of direct input from frontal regions to the STN.
In addition, connections between mediodorsal nucleus of the
thalamus and prefrontal regions received slightly lower (but
positive) T-scores and are not shown in 3D visualizations but well
visible in 2D sections shown in Fig. 6. The bundle most negatively
associated with clinical improvement was the posterior limb of
the anterior commissure, connecting bilateral temporal cortices.
To properly define the anatomical course of this tract, we
openly released it as an atlas in stereotactic (MNI) space within
Lead-DBS software (www.lead-dbs.org). Of note, Lead-DBS is
scientific and not clinical software and the tract should not be
vacuously used for any form of clinical decision making37.
Discussion
We analyzed data from four cohorts of OCD patients with dif-
ferent DBS targets using a connectomic approach. Strikingly, the
same optimal tract target emerged when separately analyzing
either an ALIC-DBS or STN-DBS cohort, alone. Among other
regions, this bundle connected dorsal anterior cingulate and
ventrolateral prefrontal cortices to the anteriomedial STN. When
the tract was calculated on either cohort alone, it could be used to
cross-predict clinical improvement in the other cohort, respec-
tively. Furthermore, variance in clinical outcomes in two inde-
pendent test cohorts from a third and fourth center could be
ALIC predicts STN [R = 0.49; p = 0.041]











% Y-BOCS improvement (Empirical)
0 0.2 0.4 0.6




















































Fig. 3 Cross-prediction between ALIC and STN training cohorts. Top: when the tract was calculated exclusively based on data from the ALIC cohort, it
was used to calculate fiber T-scores for all patients in the STN cohort. These were correlated with clinical improvements in the STN cohort. One example
patient with strong overlap of the tract (yellow) received a high fiber T-score, whereas one with less overlap received a lower score (blue). The two
example patients are marked in the correlation plot on the left. Bottom: here, the tract was calculated exclusively on data from the STN cohort to predict
outcome in patients in the ALIC cohort. Again, two example patients are shown. Gray shaded areas in the correlation plots represent 95% confidence
intervals. Of note, here, some VTAs barely overlapped with the tract (as the blue example VTA) and consequently received a near-zero score.
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significantly predicted based on stimulation overlaps with the
tract. Finally, literature-based stimulation sites for OCD seemed
to cluster close to the identified tract. Indeed, their spatial
proximity to the tract correlated with reported clinical improve-
ments across studies.
The subthalamic nucleus receives afferents from a large portion
of the prefrontal cortex by hyperdirect pathways that are known
to traverse within the internal capsule33,38. In rodents, lesions to
such a “limbic hyperdirect pathway” led to diminished dis-
criminative accuracy and increased perseveration39. One classical
cortical region, which was described as an origin of limbic
hyperdirect input is the dACC17,33,40, which has a prominent
role in the classical cortico-striato-thalamo-cortical (CSTC)
model of OCD40 and leads to improvement of OCD
symptoms when directly lesioned in humans41. The normative
connectome analysis identified the dACC as a cortical connection
site to the identified tract, among others. Because of the high
amount of false-positive connections in diffusion MRI-based
connectomes31,42, we repeated the analysis using an atlas of
predefined anatomical tracts17. Here, the hyperdirect pathway
connecting dACC to the STN was isolated as the only of five
bundles in the ALIC that were included in the atlas (Supple-
mentary Figs. 1 and 2). Thus, hyperdirect cortical input from
dACC to STN could be an anatomical and functional substrate of
the identified bundle. In this context, it is crucial to note that the
atlas by nature cannot represent each and every white-matter
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Fig. 4 Predictions in test cohorts. Top: predictive fibers calculated on both training cohorts (Cologne & Grenoble) irrespective of their target. Red fibers
are positively associated with clinical improvement, blue fibers negatively. Bottom: the sum of aggregated fiber T-scores under each VTA predicted %-Y-
BOCS improvements in eight patients with four settings each (N= 32 stimulations) of the Madrid cohort (left) and six patients of the London cohort with
dual stimulation (four electrodes) of STN and ALIC (right). Gray shaded areas represent 95% confidence intervals. Please note that p-values in this
manuscript are based on random permutation testing. Based on classical tests, the result shown in the lower right panel would remain significant in a one-
sided test, only (p-one-sided = 0.044, p-two-sided = 0.089). A replication of this result based on anatomically predefined pathways is shown in
Supplementary Fig. 2.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16734-3
6 NATURE COMMUNICATIONS |         (2020) 11:3364 | https://doi.org/10.1038/s41467-020-16734-3 | www.nature.com/naturecommunications
bundle that exists in the ALIC / STN region and shows “gaps” in
between the included bundles (Supplementary Figs. 1 and 2).
Thus, while normative connectomes include a large number of
false-positive fibers, the atlas may instead be prone to false-
negative connections, as some tracts are simply not included. For
instance, it is known that the STN receives direct input from
other areas of the prefrontal cortex such as the ventrolateral
prefrontal cortex43. In summary, although dACC and vlPFC are
likely candidates to play a functional role, our methods and
results are unable to determine the exact cortical region(s) of
origin with absolute certainty. Despite this limitation, our results
define a precise three-dimensional reconstruction of the tract
itself (i.e. a definition of where it exactly traverses within the
ALIC) in standard stereotactic space.
A highly similar pathway that already served as a tract target in
an N = 2 case-series of OCD patients10 also traversed within the
ALIC but has instead been referred to as the superolateral branch
of the medial forebrain bundle (slMFB)37. The original anato-
mical definition of the medial forebrain bundle suggests a more
ventral route connecting the ventral tegmental area to the olfac-
tory cortex while bypassing the red nucleus laterally34. In other
words, the anatomical definition of the medial forebrain bundle
does not traverse within the ALIC. This mismatch between the
surgical target (slMFB) and anatomical literature (mfb) has
recently been confirmed by the original authors of the surgical
target and they now referred to it by vtaPP (for ventral tegmental
area projection pathway)44. This potentially misleading nomen-
clature of the surgical slMFB target has suggested that results in
two previous OCD studies would be conflicting, while anatomi-
cally, their results agreed. Both studies favored a similarly defined
tract within the ALIC, which was referred to as slMFB in one
study45 and as anterior thalamic radiation in the second24. To
readers, this suggested conflicting results while they were in fact
confirmatory (based on the location of both tracts within the
ALIC). Thus, we welcome the recent steps taken to move away
from calling the surgical target slMFB toward calling it vtaPP44.
This said, our interpretation of the identified tract differs. Our
findings reveal a tract connecting frontal areas with the STN (cf.
Supplementary Fig. 3C and results from the basal-ganglia path-
way atlas, Supplementary Figs. 1 and 2). Thus, we attribute the
tract to afferents of the STN (limbic hyperdirect pathway) as
opposed to efferents of the ventral tegmental area implied by the
term vtaPP44.
This interpretation is supported by combined analyses of dMRI
and tracing methods in nonhuman primates as well as human
subjects, which were used to segregate prefrontal fibers passing
through the internal capsule46. Fibers that originated from ven-
trolateral prefrontal cortices (areas 45 and 47) were shown to
terminate in the medial part of the STN and the MD nucleus of
the thalamus—precisely corresponding to the tract described
here. Alternatively—or additionally—the hyperdirect pathway
projecting from dACC to the STN may be functionally involved
in mediating treatment outcome. As mentioned, a strong addi-
tional hint for this latter hypothesis is that lesions to the dACC
itself have beneficiary effects on OCD41.
Based on our results, two testable hypotheses with implications
above and beyond OCD could be proposed. First, different sur-
gical targets may reduce the same symptoms equally well—
potentially by modulating the same tract or network. Second, in
addition, they may modulate not only one (shared) network but
other networks that are not shared, resulting in different changes
across other behavioral domains. This can be seen by widely
different connectivity profiles of the targets (Fig. 2, top row) and
differential effects of STN vs. ALIC stimulation on depressive/
cognitive functions described by Tyagi et al.13. Thus, one may
speculate that networks are symptom-specific (and not disease-
specific). When modulated, these networks or tracts seem to not
ameliorate a specific disease but rather specific symptoms present
in the disease.
In OCD, accordingly, different symptom types (for example
contamination vs. checking) were found to activate different
prefrontal sites (ventromedial vs. dorsolateral, respectively)47.
Similar observations were made in other diseases, before. For
instance, Akram and colleagues demonstrated that connectivity to
specific cortical regions was associated with improvement in
different clinical features of Parkinson’s disease (e.g. connectivity
to M1 preferentially reduced tremor while to the SMA reduced
rigidity and bradykinesia)25. Similarly, connectivity from elec-




























































Fig. 5 Literature defined OCD targets in relationship to the identified
tract. Overview of the positively predictive fiber tracts identified in the
present study are shown in synopsis with DBS targets for treatment of OCD
from reported studies. Note that most targets were reported for the tip of
the electrode, thus, active stimulation may have occurred dorsal to shown
targets (Table 2). a, b Reported average targets mapped to standard space.
c The degree of weighted overlap between stimulation sites and the
identified tract. These were correlated with reported average %-Y-BOCS
improvements of published studies (where available, other sites marked in
gray; see Supplementary Methods for details). Gray shaded area represents
95% confidence intervals.
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Supporting the first hypothesis, our study was able to predict
symptom-specific clinical improvement across DBS targets and
centers based on connectivity data. Although the tract that our
data seems to shape out is predictive for Y-BOCS improvement,
different tracts could have emerged when repeating the analyses
for depressive or cognitive flexibility symptoms (as analyzed by
Tyagi et al.13).
Going further, shared symptom networks could be present in
other diseases for which multiple surgical targets are investigated.
Major depression and Tourette’s syndrome are obvious examples and
extensive work in this direction is currently ongoing14,49,50. Similar
concepts could even be applied to more established targets such as
STN vs. GPi DBS51 or symptom-specific alleviations across diseases.
Potentially, DBS surgery in the (distant) future could involve
detailed preoperative phenotyping to establish a broad patient-
specific symptom score. Based on databases of clinical improve-
ments along affected symptom axes, a mix of networks that
should be modulated to alleviate each patient’s specific symptom
profile could be identified. Such concepts are still mostly spec-
ulation but could be investigated in future studies. This said, we
must emphasize that the present study investigated data on a
group level and utilized connectivity data from individuals
without OCD. As mentioned by others in the very context, we
could not agree more that surgical decision making for DBS
should not be based on such aggregated normative data, alone37.
Further studies are required to determine whether individual
patient connectivity or generic connectome data (or both) could
assist with optimizations in surgical targeting or DBS program-
ming by determining crossing sites of symptom networks for
specific patients.
Table 2 DBS targets for treatment of OCD defined in the literature.
DBS target References Number of
patients
% Y-BOCS change AC/PC coordinates Relative to Target type MNI coordinates (Fig. 5)
STN Mallet et al.66 8 32.1 NA AC Tip of the
electrode
±11.30 −9.90 −7.81
amGPi Nair et al.9 4a NA ±14.47 9.85 −3.28 MCP Tip of the
electrode
±15.66 −1.41 −8.22
VC/VS Tsai et al.67 1 7.7 ±7.5 16.3 −3.05 MCP Tip of the
electrode
±7.92 5.51 −9.01
slMFB Coenen et al.10 2 41.7 (at 12 months) ±7.6 −1.72 −3.0 MCP Active contacts ±8.35 −13.64 −7.00
NAcc Sturm et al.5 4 NA ±6.5 2.5 −4.5 AC Tip of the
electrode
±6.98 3.69 −10.55
ALIC Nuttin et al.68 6 38.7 ±13 3.5 0 AC Tip of the
electrode
±13.84 5.17 −5.04
MD Maarouf et al.11 4 10.7 ±4.7 −18.52 4.87 AC Active contacts ±5.10 −18.17 2.59
VA Maarouf et al.11 4 10.7 ±6.84 −13.76 7.78 AC Active contacts ±7.52 −12.68 5.60
iml Maarouf et al.11 4 10.7 ±5.78 −14.9 7.08 AC Active contacts ±6.36 −13.99 4.85
ITP Lee et al.69 5 52.0 ±6.5 −3 −0.5 AC Tip of the
electrode
±6.92 −1.84 −5.13
BNST Nuttin et al.70 4 NA ±6 0 0 AC Tip of the
electrode
±6.33 1.39 −4.87
MD medial dorsal thalamic nucleus, VA ventral anterior thalamic nucleus, iml internal medullary lamina, MCP mid-commissural point, AC anterior commissure.
aTourette patients, with prominent symptoms of OCD.
z = –2 mm z = 0 mm z = 2 mm
x = 8 mm x = 16 mm x = 22 mm
sum (T ) 200–200
Fig. 6 Anatomical course of discriminative fibers shown in MNI space. The tract is connected to the subthalamic nucleus and mediodorsal nucleus of the
thalamus, traverses through the anterior limb of the internal capsule and has a wide array of frontal connections including dorsal anterior cingulate cortex
and ventrolateral prefrontal cortex. The tract most negatively associated with clinical improvement was the anterior commissure.
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Several limitations apply for the current work. First and fore-
most, the retrospective character of the study is not ideal to
compare and study effects of clinical outcome which is why we
kept clinical information to a minimum and instead referred to
the underlying clinical studies.
Second, it has been shown that dMRI-based tractography
reconstructs a very high proportion of false-positive fibers in
recent open challenges31,42. We aimed at reducing the risk of
false-positive tractography results in four ways. First, we used the
tracking method that achieved the highest (92%) valid connection
score among 96 methods submitted from 20 different research
groups in a recent open competition31. Second, we used highest
quality multi-shell diffusion data52 acquired on a high N
(985 subjects) at a state-of-the-art imaging center (HCP data
acquired at Washington University in St. Louis, see Acknowl-
edgements). Third, we compared the tract results with anatomy
text-books and discussed its validity with four anatomists (see
Acknowledgements). Fourth, we replicated findings based on an
atlas that is based on predefined anatomical tracts (Supplemen-
tary Methods). The tract described in the present study matches
results from this atlas (Supplementary Figs. 1 and 2). However,
the potential that the tract represents a false-positive result may
not be completely ruled out given the fundamental limitations of
dMRI-based tractography31,42.
Third, we used normative connectome data instead of patient-
specific diffusion-weighted MRI data (which is not available for
most of the patients included). This poses marked limitations as
such data cannot be representative of patient-specific anatomical
variations. Still, we argue that some aspects about general
pathophysiological mechanisms may be investigated using nor-
mative data and robust cross-validations across cohorts shown
here suggest this holds true. Use of normative connectomes has
been introduced in other clinical domains where patient-specific
MRI data is unavailable, such as stroke53,54 or transcranial
magnetic stimulation55. In DBS, the technique has been applied
before and has led to models that could be used to predict
improvements in out-of-sample data22,24. In addition to the
practical advantage of being applicable to cases where patient-
specific data is lacking, normative data also has the theoretical
advantage of better data quality. In the present case, a con-
nectome dataset was derived from a high N of 985 subjects
scanned under research conditions by a specialized imaging
center52. It may be logistically challenging to acquire data of such
quality in a clinical routine setting (e.g. pre-operatively) in indi-
vidual patients but could be feasible in specialized centers. Still,
studies have pointed out that tractography-based DBS targets
pointed to coordinates that were sometimes >2 mm apart from
each other when repeating analyses on test–retest scans of the
same subject56. Similarly, variance introduced by single subject
scans was too high to be useful in a test–retest study that aimed at
creating clinically useful and robust thalamic DBS targets57.
However, patient-specific connectivity can never be reconstructed
when using normative connectomes. Thus, normative con-
nectomes will likely not embody the final solution to the con-
nectomic surgery framework and will be challenged by advances
in MRI technology and algorithm developments. Potentially, as a
step in-between, using combined information from normative
and patient-specific connectomes could embody a promising
strategy that should be explored, in the future.
Fourth, inaccuracies in lead localization may result from the
approach of warping electrodes into common space as done here.
To minimize this issue, we used a modern neuroimaging pipeline
that has been scientifically validated in numerous studies and
involved advanced concepts such as brain shift correction58,
multispectral normalization, subcortical refinement58 and
phantom-validated electrode localizations59. The normalization
strategy that was applied was found to automatically segment the
STN as precisely as manual expert segmentations60 and each step
of the pipeline was carefully assessed and corrected if needed by a
team with long-standing expertise in this area58,61. Besides, both
post-operative CT (33 patients) and post-operative MRI (17
patients) were used for electrode localization in the current
dataset. Although studies have reported similar agreement
between the results based on the two modalities, this might still
lead to slight inconsistencies across patients. A larger dataset
acquired with a homogeneous protocol would be ideal to validate
our results, in the future.
Finally, given the correlative nature of the study, our findings
may not differentiate between local and global effects. For
instance, the tracts may have spuriously originated in the ALIC
group because a more dorsal stimulation resulted with better
clinical outcome. The congruency between results derived from
STN- and ALIC-cohorts resulting in the same fiber bundle still
suggests that the identified tract could play a causal role. How-
ever, such a claim would need to be confirmed e.g. using opto-
genetics or electrophysiology.
Four main conclusions may be drawn from the present study.
First, we show that the overall connectivity profiles of STN- and
ALIC-DBS electrodes project to largely different areas in the
brain. Second, data in each target alone singled out the same fiber
bundle that was associated with long-term improvement of OCD
symptoms when modulated either at level of the STN or the
ALIC. Third, we demonstrated that it is possible to cross-predict
clinical improvement of OCD patients across DBS target sites
(ALIC/STN) and centers (Cologne/Grenoble). Finally, we confirm
results by predicting outcome in two additional cohorts from
different centers (Madrid/London) and set results into context of
published reports.
Methods
Patient cohorts and imaging. Fifty OCD patients from four centers were retro-
spectively enrolled in this study, among them 22 patients from University Hospital
of Cologne implanted for ALIC-DBS, 14 patients from Grenoble University Hos-
pital who underwent STN-DBS surgery, 8 patients who received bilateral electrodes
targeting the NAcc from Hospital Clínico San Carlos in Madrid and 6 patients who
received electrodes to both STN and ALIC from the National Hospital for Neu-
rology and Neurosurgery in London. The patients from Cologne, Grenoble and
Madrid received two electrodes each (N= 44 patients with N= 88 electrodes), the
six patients in the London cohort received four electrodes each (N= 6 patients with
N= 24 electrodes). All patients from Grenoble were bilaterally implanted with DBS
electrodes 3389, as were all but three patients from Cologne, who received type
3387 electrodes (Medtronic, Minneapolis, Minnesota, US). Patients from London
received models 3389 to the STN and 3387 to the ALIC. Patients from Madrid
received models 3391. All patients qualified for DBS surgery based on their diag-
noses of treatment-resistant severe OCD13,24,29. Severity of OCD was assessed both
pre- and postoperatively using the Yale-Brown Obsessive-Compulsive Scale (Y-
BOCS). Post-operative assessment took place 12 months after surgery in Cologne,
Grenoble and London cohorts. In case of the London cohort, this followed a four-
step clinical trial (2 × 3 months blinded stimulation at one target followed by
6 months of stimulation at both targets, the last 3 months using clinically opti-
mized parameters. For details see ref. 13). In the Madrid cohort, each of the four
contact pairs was activated for 3 months, with a 1-month wash-out period between
trials and a 3-month sham period. In our analysis, this led to 32 data points (i.e.
stimulation-based outcomes). Patients’ demographic details are provided in
Table 1. All patients gave written informed consent. The protocols were approved
by the Ethics Committee of each center, respectively. The current study was further
approved by the local ethics committee of Charité—University Medicine Berlin in
accordance with the Declaration of Helsinki.
For all patients in the four cohorts, high-resolution structural T1-weighted
images were acquired on a 3.0-Tesla MRI scanner, before surgery. Post-operative
computer tomography (CT) was obtained in thirty-three patients after surgery to
verify correct electrode placement, while 11 patients from the Grenoble cohort and
the six London patients received post-operative MRI instead. Post-operative MRI
parameters were as follows. Grenoble cohort: T1-weighted 3D-FFE scans were
acquired on a 1.5 T Philips MRI scanner with a 1.0 × 1.0 × 1.5 mm3 voxel size; TR:
20 ms, TE: 4.6 ms, flip angle: 30 deg. London cohort: T1-weighted 3D-MPRAGE
scans were acquired on a 1.5 T Siemens Espree interventional MRI scanner with a
1.5 × 1.5 × 1.5 mm3 voxel size and three-dimensional distortion corrected using the
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scanner’s built-in module; TR: 1410 ms, TE: 1.95 ms, FOV: 282 mm, flip angle: 10
deg, acquisition time 4 min and 32 s, relative SNR: 1.0.
DBS lead localization and VTA estimation. DBS electrodes were localized using
Lead-DBS software (http://www.lead-dbs.org)58. Post-operative CT and MRI scans
were linearly coregistered to preoperative T1 images using Advanced Normal-
ization Tools (ANTs, http://stnava.github.io/ANTs/)62. Subcortical refinement was
applied (as a module in Lead-DBS) to correct for brain shift that may have
occurred during surgery. Images were then normalized into ICBM 2009b Non-
linear Asymmetric (“MNI”) template space using the SyN approach implemented
in ANTs, with an additional subcortical refinement stage to attain a most precise
subcortical alignment between patient and template space (“Effective: Low Var-
iance” preset as implemented in Lead-DBS). This specific method was top per-
former for subcortical image registrations in a recent comparative study that
involved >10,000 nonlinear warps and a variety of normalization techniques60.
Both coregistrations and normalizations were visually reviewed and refined, if
needed. DBS electrodes were then localized using Lead-DBS and warped into
MNI space.
In the Grenoble, Cologne and Madrid groups, VTA were estimated using a
finite element method (FEM)58. A volume conductor model was constructed based
on a four-compartment mesh that included gray matter, white matter, electrode
contacts and insulated parts. Gray matter was defined by the CIT-16863 and
DISTAL64 atlases for the ALIC-/NAcc and STN-cohorts, respectively. These atlases
were specifically adapted or created for use within the Lead-DBS pipeline. The
electric field (E-field) distribution was then simulated using an adaptation of the
FieldTrip-SimBio pipeline that was integrated into Lead-DBS (https://www.mrt.
uni-jena.de/simbio/; http://fieldtriptoolbox.org/) and thresholded at a level of
0.2 V/m58.
For the London test cohort, we chose to use the original VTAs of the published
study by Tyagi et al.13. These had instead been processed using Medtronic
SureTune™ software and transferred into MNI space within the original study. The
reason we chose to use the original VTAs were twofold. First, it would demonstrate
generalizability of our findings (i.e. that our results could still be useful in case
electrodes were localized using different software). Second, we aimed at yielding
maximal transferability to the study by Tyagi et al.13, which reported on the rich
London dataset in more depth.
Connectivity analysis. Structural connectivity between VTAs and all other brain
areas was calculated based on a normative connectome as similarly done in pre-
vious work22,24,32,58,64. Specifically, a whole-brain connectome based on state-of-
the-art multi-shell diffusion-weighted imaging data from 985 subjects of the
Human Connectome Project (HCP) 1200 subjects data release52 was calculated in
each patient using Lead-Connectome (www.lead-connectome.org). Whole-brain
fiber tracts were normalized into standard space using a multispectral warp based
on T1-weighted, T2-weighted, and diffusion-weighted acquisitions using ANTs
(using the same “Effective Low Variance” preset implemented in Lead-DBS). In
each subject, a total of 6000 fibers were sampled and aggregated to a joint dataset in
standard space, resulting in a set of 6,000,000 fibers across 985 HCP subjects. For
each of these tracts, a “Fiber T-score” was assigned by associating the fiber tract’s
connectivity to VTAs across patients with clinical outcome (Fig. 7). Specifically,
(mass-univariate) two-sample t-tests between clinical outcomes in connected and
unconnected VTAs were performed for all 6,000,000 tracts. Needless to say, these
T-scores were not meant to result in significant results (given the mass-univariate
nature of tests) but instead formed a model that could be used for out-of-sample
predictions in other DBS cohorts. T-values from these tests should be seen as
“weights” and could be positive or negative (since two-sided t-tests were per-
formed). A high absolute T-value meant that the fiber was strongly discriminative
between good and poor responding VTAs or predictive for clinical outcome. For
instance, a tract that was connected exclusively to VTAs in good responders (and
not to VTAs of poor responders) would receive a high positive score. In return, a
patient would most likely show more pronounced clinical benefit, if her/his VTA
was strongly connected to many fibers with high positive T-values but not too
many with negative scores. This analysis made it possible to assign aggregated fiber
T-scores to each (out-of-sample) VTA in subsequent prediction analyses.
To account for the fact that larger VTAs would potentially automatically receive
higher fiber T-scores, these were divided by the stimulation amplitude throughout
the manuscript. Finally, Monte-Carlo random permutations (×1000) were
conducted to obtain p-values, except for two-sample t-tests. This procedure is free
from assumptions about the distributions (e.g. Student t for R-values), which are
typically violated in small sample sizes65. Scatterplots were visualized with 95%
confidence bounds (gray or light-red areas).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The DBS MRI datasets generated during and analyzed during the current study are not
publicly available due to data privacy regulations of patient data but are available from
the corresponding author upon reasonable request. The resulting tract atlas is openly
available within Lead-DBS software (www.lead-dbs.org).
Code availability
All code used to analyze the dataset is openly available within Lead-DBS/-Connectome
software (https://github.com/leaddbs/leaddbs).
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